Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma

被引:110
作者
Essilfie, Ama-Tawiah
Horvat, Jay C.
Kim, Richard Y.
Mayall, Jemma R.
Pinkerton, James W.
Beckett, Emma L.
Starkey, Malcolm R.
Simpson, Jodie L.
Foster, Paul S.
Gibson, Peter G.
Hansbro, Philip M.
机构
[1] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia
[2] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
RESPIRATORY-INFECTION; CHLAMYDIA-PNEUMONIAE; AIRWAY INFLAMMATION; HYPERRESPONSIVENESS; MACROPHAGES; INTERFERON; SPUTUM; GAMMA; TARGETS; ALPHA;
D O I
10.1136/thoraxjnl-2014-206067
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Steroid-insensitive endotypes of asthma are an important clinical problem and effective therapies are required. They are associated with bacterial infection and non-eosinophilic inflammatory responses in the asthmatic lung. Macrolide therapy is effective in steroid-insensitive endotypes, such as non-eosinophilic asthma. However, whether the effects of macrolides are due to antimicrobial or anti-inflammatory mechanisms is not known. Objective To determine and assess the efficacy of macrolide (ie, clarithromycin) and non-macrolide (ie, amoxicillin) antibiotic treatments in experimental models of infection-induced, severe, steroid-insensitive neutrophilic allergic airways disease (SSIAAD), compared with steroid-sensitive AAD and to delineate the antimicrobial and anti-inflammatory effects of macrolide therapy. Methods We developed and used novel mouse models of Chlamydia and Haemophilus lung infection-induced SSIAAD. We used these models to investigate the effects of clarithromycin and amoxicillin treatment on immune responses and airways hyper-responsiveness (AHR) in Ova-induced, T helper lymphocyte (Th) 2 -associated steroid-sensitive AAD and infection-induced Th1/Th17-associated SSIAAD compared with dexamethasone treatment. Results Clarithromycin and amoxicillin had similar antimicrobial effects on infection. Amoxicillin did attenuate some features, but did not broadly suppress either form of AAD. It did restore steroid sensitivity in SSIAAD by reducing infection. In contrast, clarithromycin alone widely suppressed inflammation and AHR in both steroid-sensitive AAD and SSIAAD. This occurred through reductions in Th2 responses that drive steroid-sensitive eosinophilic AAD and tumour necrosis factor alpha and interleukin 17 responses that induce SSIAAD. Conclusions Macrolides have broad anti-inflammatory effects in AAD that are likely independent of their antimicrobial effects. The specific responses that are suppressed are dependent upon the responses that dominate during AAD.
引用
收藏
页码:458 / U151
页数:10
相关论文
共 38 条
[1]   Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma [J].
Amayasu, H ;
Yoshida, S ;
Ebana, S ;
Yamamoto, Y ;
Nishikawa, T ;
Shoji, T ;
Nakagawa, H ;
Hasegawa, H ;
Nakabayashi, M ;
Ishizaki, Y .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (06) :594-598
[2]   Interleukin-13 Promotes Susceptibility to Chlamydial Infection of the Respiratory and Genital Tracts [J].
Asquith, Kelly L. ;
Horvat, Jay C. ;
Kaiko, Gerard E. ;
Carey, Alison J. ;
Beagley, Kenneth W. ;
Hansbro, Philip M. ;
Foster, Paul S. .
PLOS PATHOGENS, 2011, 7 (05)
[3]   A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis [J].
Beckett, Emma L. ;
Stevens, Richard L. ;
Jarnicki, Andrew G. ;
Kim, Richard Y. ;
Hanish, Irwan ;
Hansbro, Nicole G. ;
Deane, Andrew ;
Keely, Simon ;
Horvat, Jay C. ;
Yang, Ming ;
Oliver, Brian G. ;
van Rooijen, Nico ;
Inman, Mark D. ;
Adachi, Roberto ;
Soberman, Roy J. ;
Hamadi, Sahar ;
Wark, Peter A. ;
Foster, Paul S. ;
Hansbro, Philip M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (03) :752-+
[4]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[5]   Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma [J].
Bhavsar, P. ;
Hew, M. ;
Khorasani, N. ;
Torrego, A. ;
Barnes, P. J. ;
Adcock, I. ;
Chung, K. F. .
THORAX, 2008, 63 (09) :784-790
[6]   Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae [J].
Black, PN ;
Blasi, F ;
Jenkins, CR ;
Scicchitano, R ;
Mills, GD ;
Rubinfeld, AR ;
Ruffin, RE ;
Mullins, PR ;
Dangain, J ;
Cooper, BC ;
David, DB ;
Allegra, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (04) :536-541
[7]   IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? [J].
Bullens, Dominique M. A. ;
Truyen, Els ;
Coteur, Liesbeth ;
Dilissen, Ellen ;
Hellings, Peter W. ;
Dupont, Lieven J. ;
Ceuppens, Jan L. .
RESPIRATORY RESEARCH, 2006, 7 (1)
[8]  
Chung KF, 1999, EUR RESPIR J, V13, P1198
[9]   Long-term macrolide therapy in chronic inflammatory airway diseases [J].
Crosbie, P. A. J. ;
Woodhead, M. A. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (01) :171-181
[10]   TNF-Alpha Antagonism in Severe Asthma? [J].
Desai, Dhananjay ;
Brightling, Christopher .
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2010, 4 (03) :193-200